Readmission Reduction Program
Respiratory Care Management for High-Risk Patients
Respiratory care management for high - risk patients such as those with congestive heart failure (CHF) or COPD improves outcomes and quality of life while reducing the overall cost of care. Sleep disorders such as sleep apnea worsen these conditions. Without respiratory care management, the average cost of CHF readmission is $15,000 and COPD readmission is nearly $10,000.
Our Readmission Reduction Program is a patient-centric method that transforms the current model of transitional care for high-risk patients with respiratory therapy needs.
It starts by identifying these high-risk inpatient populations and initiating screenings and continues with post-discharge monitoring.
The program can be customized to fit your hospital or healthcare system’s needs and can include an inpatient navigator, pre-discharge loaner equipment, and bedside consultations by board-certified sleep physicians.